Abstract:BACKGROUND:Survivin is known to be overexpressed in various human malignancies, including pancreatic cancer, and mediates cancer cell proliferation and tumor growth, so the regulation of this molecule could be a new strategy for treating pancreatic cancer. In this study, short hairpin RNAs (shRNAs) specific to survivin were introduced into human pancreatic cancer Patu8988 cells to investigate the inhibitory effects on survivin expression and cell proliferation in vitro and in vivo.METHODS:Three kinds of shRNA specific to the survivin gene were designed and cloned into eukaryotic expression plasmid pGenesil-1 vector. Subsequently the recombinant plasmids were transfected into human pancreatic cancer Patu8988 cells with lipfectamineTM 2000 reagent. The mRNA and protein expressions of survivin in the transiently transfected Patu8988 cells were determined by RT-PCR, flow cytometry, and Western blotting analysis. The proliferation inhibition rates of stably transfected Patu8988 cells were determined by MTT assay. The antitumor activities of the three kinds of survivin-shRNA plasmids were evaluated in BALB/c nude mice inoculated with Patu8988 cells and bearing human pancreatic cancer.RESULTS:The three survivin-shRNA plasmids named pGenesil-1-survivin-1, pGenesil-1-survivin-2 and pGenesil-1-survivin-1+2 (with double interfering RNA sites) were successfully constructed, and were confirmed by restriction enzyme cutting and sequencing. At 48 hours after transfection, the expression of survivin mRNA and protein was inhibited in Patu8988 cells transfected with pGenesil-1-survivin-1, pGenesil-1-survivin-2, and pGenesil-1-survivin-1+2 when compared with that of either pGenesil-1-NC (with scrambled small interfering RNA) transfected cells or control cells (P<0.05). The MTT results showed that the proliferation rates of Patu8988 cells stably transfected with survivin-shRNA plasmids were reduced when compared with that of either pGenesil-1-NC transfected cells or control cells (P<0.01). Furthermore, when Patu8988 cells stably transfected with survivin-shRNA were injected into BALB/c nude mice, tumor growth was dramatically lower and the tumor was smaller than that of either pGenesil-1-NC transfected cells or control cells (P<0.01). The inhibitory effect of pGenesil-1-survivin-1 was the best among the three kinds of survivin-shRNA plasmids, but no combination of inhibitory effects was found in pGenesil-1-survivin-1+2.CONCLUSIONS:shRNAs specific to survivin have gene silencing effects and inhibit pancreatic cancer cell proliferation. shRNA activity against survivin could be of potential value in gene therapy for pancreatic cancer. However, shRNAs with double combining sites did not significantly enhance the interference compared with single site shRNAs, therefore further studies on this are needed.

Effects of the inhibition and apoptosis by shRNA mediated survivin gene silencing in xenograft tumor of nasopharyngeal carcinoma cell CNE-2]

Survivin Special Sirna Enhanced Radiosensitivity of Nasopharyngeal Carcinoma Cells Transferred Human Sodium/iodide Symporter Gene to 131 I

Effect of shRNA mediated P2X7R silencing on cell proliferation, apoptosis and signal pathways of PI3K/Akt and Wnt/β-catenin in nasopharyngeal carcinoma

Silence of Survivin Gene by RNA Interference Inhibits the Malignant Phenotype of Nasopharyngeai Carcinoma Cell Line CNE-2

Effect of RNAi-mediated USP22 gene silencing on the growth of human nasopharyngeal carcinoma xenograph in nude mice

Inhibitory Effect of Silencing Htert Gene on Growth of Human Squamous Cell Carcinoma Xenograft in Nude Mice

Growth Inhibition Induced by Short Hairpin RNA to Silence Survivin Gene in Human Pancreatic Cancer Cells.

Survivin siRNA inhibits human laryngeal squamous carcinoma in nude mice

Survivin Downregulation By Sirna/Cationic Liposome Complex Radiosensitises Human Hepatoma Cells In Vitro And In Vivo

Novel Survivin-Targeted Small Interfering RNA Delivered by Nanoparticles.

[Inhibition of Growth and Angiogenesis of U251 Cell Xenograft in Vivo by Short Hairpin RNA Targeting Survivin Gene].

The Study of Irradiation in Combination with Endostar Therapy for Human Nasopharyngeal Carcinoma Xenografts in Nuke Mice

Anti-tumor Effect of RNA Interference Silencing Survivin Gene Combined with X-ray Irradiation on Human Hepatoma Xenograft in Nude Mice

Anti-tumor Effect of Silencing HIF-lα and Survivin Genes Combined with Radiotherapy on Human Hepatoma Xenograft in Nude Mice

Impact on U251 Cell Xenograft in vivo through Short Hairpin RNA Targeting Survivin Gene

Inhibitory Effect of Survivin-Sirna on Prostatic Subcutaneous Xenografts in Nude Mice

Anti-Tumor Effect Of Rna Interference Silencing Hif-1 Alpha And Survivin Genes Combined With X-Rays Irradiation On Human Hepatoma Xenograft In Nude Mice

[Expression and Significance of Survivin Mrna in Xenotransplanted Nasopharyngeal Carcinoma Treated by Paclitaxel Combined with Radiotherapy].

[The Effect of Shrna Targeting Htert on Telomerase and the Expression of PCNA and Caspase-3 in Nasopharyngeal Carcinoma Cells].

Effect of Adv Vector-mediated Shrna Targeting Htert on Proliferation and Apoptosis of Nasopharyngeal Carcinoma Cells

EFFECT OF SHRNA EXPRESSION VECTOR TARGETING SURVIVIN GENE ON THE SURVIVIN EXPRESSION IN THE CASKI CELL LINE